Home » Topics » Conferences

Conferences
RSS

Pharmacological profile of TBC-11251, a selective, orally active ETA antagonist

June 25, 1997

SR-49059: a selective vascular V1 receptor antagonist

June 25, 1997

Pharmacokinetics and antihypertensive efficacy of the new AII antagonist CS-866

June 25, 1997

LU-135252 evaluated in models of acute renal failure and hypertension

June 25, 1997

Preclinical and preliminary clinical results reported for alniditan

June 25, 1997

Zolmitriptan: a new antimigraine agent with peripheral and central sites of action

June 25, 1997

Preclinical studies on UR-7280, a potential antihypertensive agent

June 23, 1997

Melatonin reduces the effects of nifedipine in hypertensive patients

June 23, 1997

Triazole antifungals under development

June 20, 1997

New sordarin derivatives from Glaxo Wellcome

June 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...